Rhenman & Partners Asset Management AB - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,581,000
-22.5%
50,0000.0%0.17%
-20.9%
Q2 2023$2,039,000
+13.2%
50,0000.0%0.22%
+8.6%
Q1 2023$1,801,000
+3.2%
50,0000.0%0.20%
+8.8%
Q4 2022$1,744,500
-33.9%
50,0000.0%0.18%
-34.1%
Q3 2022$2,639,000
+2.0%
50,0000.0%0.28%
-6.1%
Q2 2022$2,588,000
-28.8%
50,0000.0%0.29%
-18.1%
Q1 2022$3,634,00050,0000.36%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders